Kira Biotech

First-in-class monoclonal antibody drug for treating immune disorders.

Visit Website
north_east
Synopsis

Led $20M Series A (October 2019)

chevron_leftPreviosly
Blade Therapeutics
18 May 2022
Nextchevron_right
Axial Biotherapeutics
18 May 2022
decor decor decor
decor decor decor decor decor